Holen Sie sich die Stockscreener-App
35.70
0.11%
0.04
Handel nachbörslich:
35.80
0.10
+0.28%
Schlusskurs vom Vortag:
$35.66
Offen:
$35.67
24-Stunden-Volumen:
406.20K
Relative Volume:
0.83
Marktkapitalisierung:
$1.72B
Einnahmen:
$723.55M
Nettoeinkommen (Verlust:
$157.72M
KGV:
11.90
EPS:
3
Netto-Cashflow:
$170.15M
1W Leistung:
-1.82%
1M Leistung:
-12.61%
6M Leistung:
-9.44%
1J Leistung:
-36.41%
1-Tages-Spanne:
$35.27
$35.95
1-Wochen-Bereich:
$34.60
$39.01
52-Wochen-Spanne:
$34.60
$56.88
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Firmenname
Amphastar Pharmaceuticals Inc
Sektor
Telefon
909-980-9484
Adresse
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Vergleichen Sie AMPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
35.70 | 1.72B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
165.89 | 74.84B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.92 | 40.96B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.92 | 24.83B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
143.26 | 14.50B | 2.24B | 385.90M | 440.10M | 3.73 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2023-07-25 | Fortgesetzt | Jefferies | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-07-29 | Eingeleitet | CapitalOne | Overweight |
| 2022-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-03-13 | Herabstufung | Needham | Buy → Hold |
| 2019-03-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Bestätigt | Needham | Buy |
| 2018-03-13 | Bestätigt | Needham | Buy |
| 2017-12-01 | Bestätigt | Needham | Buy |
| 2017-11-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Bestätigt | Needham | Buy |
| 2017-03-14 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-05-10 | Bestätigt | Needham | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2015-06-19 | Bestätigt | Needham | Buy |
| 2015-06-03 | Eingeleitet | Raymond James | Strong Buy |
| 2014-07-21 | Eingeleitet | Needham | Buy |
Alle ansehen
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Assenagon Asset Management S.A. Sells 5,956 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 10.3% in December - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowTime to Sell? - MarketBeat
Amphastar stock hits 52-week low at $34.6 amid market challenges - Investing.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 2.4%Should You Sell? - MarketBeat
Dextrose Injection Market Size, Share & Trending Opportunities - WICZ
Dextrose Injection Market Size, Share & Trending Opportunities (2024-2031) | Pfizer Inc., Amphastar Pharmaceuticals Inc. - EIN News
Trend Tracker for (AMPH) - Stock Traders Daily
Oversold Conditions For Amphastar Pharmaceuticals (AMPH) - Nasdaq
Amphastar stock hits 52-week low at $34.85 amid market challenges - Investing.com Nigeria
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 4.6%What's Next? - MarketBeat
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - AccessWire
Amphastar stock hits 52-week low at $34.85 amid market challenges By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
Amphastar Pharmaceuticals: Cheap With Caveats (NASDAQ:AMPH) - Seeking Alpha
(AMPH) Technical Data - Stock Traders Daily
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Expands By 6.1% - Defense World
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Increases By 6.1% - MarketBeat
Amphastar stock hits 52-week low at $36.55 amid market challenges - Investing.com Australia
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 1-Year LowHere's Why - MarketBeat
Amphastar stock hits 52-week low at $36.55 amid market challenges By Investing.com - Investing.com South Africa
Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
New Strong Sell Stocks for December 31st - Yahoo Finance
Principal Financial Group Inc. Lowers Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Boosted by Sanctuary Advisors LLC - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Down 2.6%Time to Sell? - MarketBeat
Geode Capital Management LLC Has $44.67 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Geode Capital Management LLC Grows Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Trading Report - Stock Traders Daily
Barclays PLC Buys 25,878 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
19,723 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Bought by Wellington Management Group LLP - MarketBeat
Hyaluronidase Market Massive Growth Predicted (2024-2031) | - openPR
Amphastar Pharmaceuticals executive sells shares worth $672,815 By Investing.com - Investing.com Australia
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 7,000 Shares of Stock - MarketBeat
Amphastar Pharmaceuticals executive sells shares worth $672,815 - Investing.com
Amphastar Pharmaceuticals Enters Oversold Territory (AMPH) - Nasdaq
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Prospects Need A Boost To Lift Shares - Simply Wall St
World Investment Advisors LLC Takes $1.61 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 5.4%What's Next? - MarketBeat
XTX Topco Ltd Buys New Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
The Manufacturers Life Insurance Company Trims Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Decreased by Centiva Capital LP - MarketBeat
Point72 Asset Management L.P. Sells 197,019 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals Breaks Above 200-Day Moving AverageBullish for AMPH - Nasdaq
Charles Schwab Investment Management Inc. Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Taika Capital LP Makes New $1.79 Million Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today? - Yahoo Finance
Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):